Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness... see more

Bullboard (NDAQ:INM)

View:
Post by Bullknit101on Nov 13, 2021 10:52pm

The Dales Report nMed Update

https://youtu.be/8O3jaEj35Pg
Post by Bullknit101on Nov 13, 2021 7:28am

Peregrine Precision Systems

https://www.newsfilecorp.com/release/103238/Peregrine-Precision-Systems-Inc.-Ramps-Up-Production-of-Rare-Natural-Synthetic-Cannabinoids-Through-Naturally-Synthetic-Inc.-Joint-Venture
Post by Bullknit101on Nov 13, 2021 7:13am

Rare Cannabinoids

All about rare cannabinoids: https://www.rarecannabinoidco.com/
Post by Bullknit101on Nov 11, 2021 11:56am

Q1 Update

https://www.nasdaq.com/articles/inmed-pharmaceuticals-inc.-inm-reports-q1-loss-lags-revenue-estimates
Post by gainwidpatienceon Nov 11, 2021 10:08am

My dear FB friends

I hope someone raises shareholders concerns to the board rather than telling "it's the perfect time to buy". All our hard earned money is just getting disappeared.
Post by magicman30on Nov 08, 2021 6:51pm

Dales Report

https://youtu.be/8O3jaEj35Pg
Post by Bullknit101on Nov 07, 2021 8:34am

Cannabis Stocks Bottom

The news, short squeeze on Friday from 3:17pm lifting the whole Cannabis Sector will likely continue Monday along with US MSOS earnings all week. What's good for the sector will hopefully boost ...more  
Post by Bullknit101on Nov 07, 2021 3:40am

Cannabinoid Research Lab

https://www.thedenverchannel.com/news/national/new-cannabinoid-lab-could-be-game-changer-for-future-medical-research
Post by Bullknit101on Nov 05, 2021 11:49pm

Medical Cannabis Oncology

https://www.onclive.com/view/a-primer-on-rising-medical-cannabis-use-in-oncology
Post by Bullknit101on Nov 03, 2021 7:56am

PCT Filing

https://seekingalpha.com/news/3763784-inmed-files-pct-patent-application-for-treating-neurodegenerative-disease
Post by Bullknit101on Nov 01, 2021 5:12pm

Ginkgo

https://www.streetinsider.com/dr/news.php?id=19137819&gfv=1
Post by Bullknit101on Oct 31, 2021 9:15am

Rare cannabinoid market picking up

https://youtu.be/RgW965D4IqE
Post by Bullknit101on Oct 29, 2021 1:54pm

THCV Please

Type 2 diabetes and weight control: https://www.westword.com/marijuana/marijuana-edibles-makers-dabbling-thcv-weight-control-products-12592435
Post by Bullknit101on Oct 29, 2021 7:14am

Big Pharma Canabinoids Prescriptions

Time for big pharma to get onboard with cannabinoid medicine. https://www.karger.com/Article/FullText/512342
Post by Bullknit101on Oct 27, 2021 10:48pm

Lygos

https://www.businesswire.com/news/home/20211027005178/en/Lygos-Successfully-Completes-Commercial-Scale-Fermentation-Campaign-to-Meet-Growing-Demand-for-Bio-based-Cannabinoids
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities